A “cancer killer” virus is being tested on a patient in a clinical trial

you will also be interested

[EN VIDÉO] What is the difference between bacteria and virus?
They are germs. They are very small and they get confused quite easily. However, bacteria and viruses are two very different things. And in order to effectively fight against those that cause the disease, it is better to clearly identify them.

as part of a clinical trialsponsored by the company of Biotechnology Australian Imagination, a volunteer cancer metastasized and resistant to previous treatment attempts, have just been administered virus “Cancer killer”, or oncolytic to scientists. CF33-hNIS or Vaccinia is an orthopoxvirus like monkeypox, which has been modified in the laboratory to express . Ashamed human – then we talk of a virus incurable – which makes it possible to follow replica in cells and enhances its anti-cancer properties.

The latter is able to infect and kill cancer cells while sparing healthy ones. When a cancer cell dies, it releases virus particles that stimulate them immune systemSpecially T cells specialized in tumor destruction, who then attack their neighbors. , Our previous research has shown that oncolytic viruses can stimulate the immune system to kill cancer and make it more reagent For other immunotherapy , Dareng Lee, principal investigator of this clinical trial, explains,

A new approach to cancer on the test bench

Clinical trials will test the safety and tolerability of CF33-hNIS alone or in combination with therapeutic antibodies, pembrolizumab, is already authorized for the treatment of many cancers. Second, scientists will analyze the ability to reduce the size of oncolytic viruses tumor,

See also  Earth will shift to new house named Milkomeda, know what will happen when giant galaxy collides with Milky Way

Actual effectiveness of this treatment anticancer Only during the later stages of the clinical trial will the estimate be made. investigators expect to be victimized by a hundred volunteers, adults and any tumor type Solidacross the United States and Australia.

Do you want to access Futura without being interrupted by advertising?

find us online subscription And browse without ads! This time, Mag Futura is offered For a 3-month subscription to the “I participate in the life of Futura” subscription!

I take advantage of the offer before May 31st!

What is Mag Future?

  • Our first paper journal of over 200 pages to make science accessible to as many people as possible
  • Dive into the heart of the 4 scientific disciplines that will mark 2022, from Earth to the Moon

*Mag Futura is sent after the third month of registration.

Interested in what you just read?

You May Also Like

About the Author: Abbott Hopkins

Analyst. Amateur problem solver. Wannabe internet expert. Coffee geek. Tv guru. Award-winning communicator. Food nerd.

Leave a Reply

Your email address will not be published.